GlassScriptPhysician profile
William Zimmerman
NPI 1639265614
$850.91
in general payments reported to CMS, 2019-2025
13 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $57.62 · 2021: $84.14 · 2022: $63.39 · 2023: $163 · 2024: $96.03 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $528.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $217.55 | 2021-2025 | Nucala |
| Acclarent, INC | $107.22 | 2019-2023 | Acclarent Navwire, Acclarent Aera |
| Regeneron Healthcare Solutions, INC. | $107.09 | 2019-2024 | Dupixent |
| Inspire Medical Systems, INC. | $76.34 | 2023 | Inspire |
| Stryker Corporation | $73.26 | 2020-2025 | Xpress Loprofile |
| Genzyme Corporation | $72.11 | 2025 | |
| Aerin Medical INC. | $66.03 | 2020-2024 | |
| Neurent Medical Limited | $34.83 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Cochlear Americas | $28.05 | 2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Optinose US, INC. | $20.68 | 2019 | |
| Alk-Abello, INC | $18.56 | 2021 | |
| Amneal Pharmaceuticals LLC | $16.31 | 2020 | |
| Medtronic USA, INC. | $12.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Zimmerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.